← Back to Discover
Lynx1 Capital Management LP
Period ended Jun 30, 2026 · Latest filing Aug 13, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $865,529,222
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- GH RESEARCH PLC · ORDINARY SHARES · G3855L106 · shares: $356,517,181
- CULLINAN THERAPEUTICS INC · COM · 230031106 · shares: $163,225,335
- STOKE THERAPEUTICS INC · COM · 86150R107 · shares: $132,136,579
- AGIOS PHARMACEUTICALS INC · COM · 00847X104 · shares: $126,505,652
- C4 THERAPEUTICS INC · COM STK · 12529R107 · shares: $34,215,647
- KORRO BIO INC · COM · 500946108 · shares: $20,274,741
- TSCAN THERAPEUTICS INC · COM · 89854M101 · shares: $7,859,567
- PRECISION BIOSCIENCES INC · COM NEW · 74019P207 · shares: $7,470,663
- NEUPHORIA THERAPEUTICS INC · COM · 64136E102 · shares: $3,825,183
- PASSAGE BIO INC · COM NEW · 702712209 · shares: $3,287,942
Reported holdings
27 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | — | 13,263,288 shares | $356,517,181 |
| CULLINAN THERAPEUTICS INC | COM | 230031106 | — | 8,963,500 shares | $163,225,335 |
| STOKE THERAPEUTICS INC | COM | 86150R107 | — | 4,038,404 shares | $132,136,579 |
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | — | 3,408,937 shares | $126,505,652 |
| C4 THERAPEUTICS INC | COM STK | 12529R107 | — | 7,326,691 shares | $34,215,647 |
| KORRO BIO INC | COM | 500946108 | — | 1,538,296 shares | $20,274,741 |
| TSCAN THERAPEUTICS INC | COM | 89854M101 | — | 8,019,148 shares | $7,859,567 |
| PRECISION BIOSCIENCES INC | COM NEW | 74019P207 | — | 950,466 shares | $7,470,663 |
| NEUPHORIA THERAPEUTICS INC | COM | 64136E102 | — | 875,328 shares | $3,825,183 |
| PASSAGE BIO INC | COM NEW | 702712209 | — | 673,759 shares | $3,287,942 |
| CG ONCOLOGY INC | COM | 156944100 | — | 31,391 shares | $2,230,331 |
| PLIANT THERAPEUTICS INC | COM | 729139105 | — | 1,798,070 shares | $2,049,800 |
| ENTRADA THERAPEUTICS INC | COM | 29384C108 | — | 178,606 shares | $1,314,540 |
| VYNE THERAPEUTICS INC | COM | 92941V308 | — | 1,628,700 shares | $1,059,795 |
| PROQR THRAPEUTICS N V | SHS EURO | N71542109 | — | 521,413 shares | $969,828 |
| TRAWS PHARMA INC | COM NEW | 68232V884 | — | 559,470 shares | $471,801 |
| FOGHORN THERAPEUTICS INC | COM | 344174107 | — | 61,588 shares | $300,549 |
| DENALI THERAPEUTICS INC | COM | 24823R105 | — | 11,658 shares | $299,844 |
| XENCOR INC | COM | 98401F105 | — | 18,194 shares | $292,923 |
| ABSCI CORPORATION | COM | 00091E109 | — | 21,245 shares | $246,230 |
| WEREWOLF THERAPEUTICS INC | COM | 95075A107 | — | 657,786 shares | $236,737 |
| IMMATICS N.V | SHS | N44445109 | — | 23,236 shares | $235,381 |
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | — | 10,100 shares | $186,648 |
| BOLT BIOTHERAPEUTICS INC | COM NEW | 097702203 | — | 30,800 shares | $118,580 |
| NUVATION BIO INC | COM CL A | 67080N101 | — | 16,029 shares | $91,045 |
| EUPRAXIA PHARMACEUTICALS INC | COM | 29842P105 | — | 10,000 shares | $66,100 |
| INHIBIKASE THERAPEUTICS INC | COM NEW | 45719W205 | — | 20,000 shares | $40,600 |